DHR
NYSE
$201.52
Danaher Corp (DHR)
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $242.52 (+20.35%)
Market Cap
$142B
Forward P/E
24.10
P/E Ratio
38.55
Free Cash Flow Yield
3.72%
Price Chart
Valuation
Market Cap$142B
P/E38.55
Forward P/E24.10
PEG1.28
P/S5.69
P/B2.67
Profitability
Total Revenue (TTM)$25B
Gross Profit (TTM)$15B
EBITDA$5.52B
Profit Margin17.3%
Operating Margin22.6%
EPS$5.21
Financial Health
Debt-to-Equity34.9%
Free Cash Flow Yield3.72%
Dividend Yield0.66%
Growth & Risk
EPS 5Y CAGR-4.86%
Revenue 5Y CAGR-0.02%
FCF 5Y CAGR-3.58%
Dividends 5Y CAGR+17.67%
Beta (5Y)0.79
Sharpe Ratio0.15